Skip to Content

February 24, 2022, 12:30 PM

Watch Videos

Online Viewing

Event Description

Psychedelic substances such as psilocybin, MDMA, and ketamine are being used increasingly in research and clinical settings. They also are being decriminalized and legalized by cities and states across the country. As research and access advance, a growing body of evidence suggests that one promising application for psychedelics is in the treatment of various types of trauma.

This panel will assemble doctors, lawyers, academics, entrepreneurs, and activists to discuss the emerging role of psychedelics in addressing the symptoms of racial trauma, post-traumatic stress disorder, and trauma associated with violence and emotional and sexual abuse. Panelists will address how psychedelics law and policy can help resolve or potentially exacerbate trauma.

Join the conversation and submit questions on Twitter @PetrieFlom using #POPLAR.

Panelists

  • Introduction: Carmel Shachar, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
  • Jeannie Suk Gersen, John H. Watson, Jr. Professor of Law, Harvard Law School

  • Jesse Gould, Founder & President, Heroic Hearts Project

  • Rachel Knox, MD, Oregon Psilocybin Advisory Board and Co-Chair of the Health Equity Subcommittee

  • Ronan Levy, Co-Founder & Executive Chairman of Field Trip Health

  • Tatiana Quintana, Co-Director of the Psychedelic Medicine Alliance of Washington (PMAW) and Decriminalize Nature Seattle

  • Moderator: Mason Marks, MD, JD, Assistant Professor of Law, University of New Hampshire Franklin Pierce School of Law; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School


Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School with support from the Oswald DeN. Cammann Fund at Harvard University.


Video

VIDEO: Psychedelics and Trauma

Tags

health law policy   poplar   public health   regulation